Calcipotriene, Betamethasone Dipropionate

FDA Drug Profile — Calcipotriene and Betamethasone Dipropionate

Calcipotriene, Betamethasone Dipropionate is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including Calcipotriene and Betamethasone Dipropionate. Available dosage form: ointment.

Drug details

Generic Name
Calcipotriene, Betamethasone Dipropionate
Brand Names
Calcipotriene and Betamethasone Dipropionate
Application Number
ANDA200174
Sponsor
Padagis Israel Pharmaceuticals Ltd
NDC Codes
4
Dosage Forms
OINTMENT
Routes
TOPICAL
Active Ingredients
CALCIPOTRIENE, BETAMETHASONE DIPROPIONATE

Indications and Usage

1 INDICATIONS AND USAGE Calcipotriene and Betamethasone Dipropionate Ointment is indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older. Calcipotriene and Betamethasone Dipropionate Ointment is a vitamin D analogue and corticosteroid combination product indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.